| 000 | 01624 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511232552.0 | ||
| 264 | 0 | _c19910308 | |
| 008 | 199103s 0 0 eng d | ||
| 022 | _a0902-4506 | ||
| 024 | 7 |
_a10.1111/j.1600-0609.1990.tb00904.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArcese, W | |
| 245 | 0 | 0 |
_aAlpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantation. _h[electronic resource] |
| 260 |
_bEuropean journal of haematology. Supplementum _c1990 |
||
| 300 |
_a36-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xpathology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aT-Lymphocytes |
| 700 | 1 | _aMauro, F R | |
| 700 | 1 | _aScrenci, M | |
| 700 | 1 | _aAlimena, G | |
| 700 | 1 | _aIori, A P | |
| 700 | 1 | _aDe Cuia, M R | |
| 700 | 1 | _aLo Coco, F | |
| 700 | 1 | _aMontefusco, E | |
| 700 | 1 | _aFazi, P | |
| 700 | 1 | _aMandelli, F | |
| 773 | 0 |
_tEuropean journal of haematology. Supplementum _gvol. 52 _gp. 36-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.1990.tb00904.x _zAvailable from publisher's website |
| 999 |
_c2285623 _d2285623 |
||